Antibiotic resistance remains a significant challenge for healthcare providers globally. Specifically, the evolution of resistance enzymes like TEM-1 β-lactamase reveals complex survival strategies beyond simple catalytic efficiency. Recent research highlights the critical role of **TEM-1 collateral fitness effects** (CFEs). These effects refer to fitness changes caused by mutations that do not directly alter the protein's primary physiological function, such as its ability to hydrolyze antibiotics. Understanding these mechanisms is essential for predicting how resistance persists in diverse clinical environments.

Modulating TEM-1 Collateral Fitness Effects

Environmental factors play a massive role in shaping these fitness landscapes. For instance, researchers found that reducing growth temperature or shifting to minimal media significantly decreases the frequency of deleterious mutations. These environmental shifts disfavor protein aggregation, which is a major driver of negative fitness outcomes. Consequently, the magnitude of **TEM-1 collateral fitness effects** diminishes under these conditions. This suggests that the metabolic and thermal environment of the host could influence the evolutionary trajectory of resistant bacteria.

The Role of Protein Stability and Suppressors

Mutational stabilization offers another pathway to modulate these effects. The M182T mutation, often called a \"global suppressor,\" enhances the thermodynamic stability of the enzyme. Furthermore, the addition of the β-lactamase inhibitor avibactam can also stabilize TEM-1. These stabilizers mitigate the negative impacts of other mutations by preventing the exposure of deleterious motifs. Interestingly, the study proposes that while destabilization exposes motifs that cause fitness loss, these are not always the same motifs that trigger aggregation. Thus, the relationship between protein stability and cellular fitness is more nuanced than previously understood.

Clinical Implications for Resistance Management

By identifying the motifs exposed during protein destabilization, scientists may develop new strategies to target resistant strains. These findings indicate that antibiotic resistance is not solely about enzyme activity. Instead, it involves a delicate balance of protein folding and cellular stress. Consequently, future therapies might focus on exacerbating these collateral fitness costs to eliminate resistant populations more effectively.

FAQ: Frequently Asked Questions

What are collateral fitness effects?

Collateral fitness effects (CFEs) are changes in an organism's fitness caused by mutations that do not affect the protein's primary physiological function. In the case of TEM-1, these effects often relate to protein aggregation and cellular stress rather than antibiotic hydrolysis.

How does the M182T mutation assist resistant bacteria?

The M182T mutation acts as a global suppressor. It increases the thermodynamic stability of TEM-1 β-lactamase, which compensates for the destabilizing effects of other mutations that might have been selected to increase antibiotic resistance.

Can environmental changes impact antibiotic resistance?

Yes. Changes in temperature and nutrient availability can modulate the fitness costs associated with resistance mutations. For example, lower temperatures can reduce protein aggregation, thereby making certain resistance mutations less harmful to the bacteria.

Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

Goff C et al. Environmental and mutational modulation of collateral fitness effects informs their mechanisms. Mol Biol Evol. 2026 Apr 21. doi: undefined. PMID: 42012237.

Mehlhoff JD et al. Collateral fitness effects of mutations. Proc Natl Acad Sci U S A. 2020 May 26;117(21):11597-11607. doi: 10.1073/pnas.1918680117.

Huang W et al. A natural polymorphism in β-lactamase is a global suppressor. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12643-8. doi: 10.1073/pnas.94.23.12643.

"